FDA Approvals in Non-Hodgkin Lymphoma, Breast Cancer, GVHD, and Mesothelioma
1 Views
administrator
07/09/23
Kristi Rosa reports on FDA approvals in non-Hodgkin lymphoma, breast cancer, graft-versus-host disease, and mesothelioma, and a breakthrough therapy designation in cervical cancer.
-
Category
Show more
Facebook Comments
No comments found